Chemoinformaics analysis of 2-Deoxy-20-hydroxyecdysone
| Molecular Weight | 464.643 | nRot | 5 |
| Heavy Atom Molecular Weight | 420.291 | nRig | 21 |
| Exact Molecular Weight | 464.314 | nRing | 4 |
| Solubility: LogS | -3.417 | nHRing | 0 |
| Solubility: LogP | 1.849 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 79.2409 |
| nHD | 5 | BPOL | 45.0091 |
| QED | 0.399 |
| Synth | 5.17 |
| Natural Product Likeliness | 3.103 |
| NR-PPAR-gamma | 0.608 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.049 |
| Pgp-sub | 0.058 |
| HIA | 0.315 |
| CACO-2 | -4.906 |
| MDCK | 0.0000172 |
| BBB | 0.978 |
| PPB | 0.776484 |
| VDSS | 1.208 |
| FU | 0.124422 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.304 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.839 |
| CYP2c9-inh | 0.063 |
| CYP2c9-sub | 0.238 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.062 |
| CYP3a4-sub | 0.72 |
| CL | 4.597 |
| T12 | 0.181 |
| hERG | 0.027 |
| Ames | 0.126 |
| ROA | 0.789 |
| SkinSen | 0.045 |
| Carcinogencity | 0.042 |
| EI | 0.011 |
| Respiratory | 0.474 |
| NR-Aromatase | 0.734 |
| Antiviral | Yes |
| Prediction | 0.793013 |